Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...

A new study casts doubt on international guidelines advising up to a week of prophylactic antibiotics in patients with cirrhosis and upper gastrointestinal (GI) bleeding. Pooled data from 14 ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

Researchers have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning ...

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson's disease. The retrospective study followed GI patients for nearly 15 years. The findings support literature suggesting ...

Please provide your email address to receive an email when new articles are posted on . Chan and colleagues assessed data on 19,114 patients from Aspree, an aspirin primary prevention trial. In the ...

Irinotecan plus S-1 (IRIS) versus S-1 alone as first line treatment for advanced gastric cancer: Preliminary results of a randomized phase III study (GC0301/TOP-002) No significant financial ...